Trident Lifeline Limited - pharma in Surat, Gujarat, India. FY 2026 financials & compliance.
CIN L51909GJ2014PLC078227 Incorporated 09 January 2014 ROC Ahmedabad HQ Surat, Gujarat, India
Active Listed - BSE: 543616 Public Limited Company pharma
Market Cap
₹491 Cr
TLL · BSE
Share Price
₹406.05
-0.96% today
Revenue
₹129 Cr
FY 2025-26 · +48.4% YoY
EBITDA
₹28.11 Cr
Margin 21.8%
Net Profit
₹19.03 Cr
FY 2025-26 · +62.2% YoY
P/E (TTM)
21.1x
P/B 4.2x
ROE
23.4%
ROCE 22.3%
Debt / Equity
0.77
Interest cover 24.1x

About Trident Lifeline Limited

Data last updated:

Trident Lifeline Limited is a public limited company based in Surat, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 January 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L51909GJ2014PLC078227. Its GSTIN is 24AAECT8906D1ZG (Gujarat). It is a listed company as per MCA records. Its shares are listed on BSE: 543616.

The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹11.96 Cr. It is led by directors including Shravan H Patel (Managing Director) and Rupaben Chetan Jariwala (Whole-Time Director).

Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 2nd Floor Shop – 2004 North Extension Falsawadi Begumpura Nodh – 4/1650 Sahara Darwaja, Surat, Gujarat, India – 395003.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹129.02 Cr, a growth of 48.4% compared to the previous year. For the same year it recorded a net profit of ₹19.03 Cr (net margin 14.7%) and EBITDA of ₹28.11 Cr (EBITDA margin 21.8%). The net worth stands at ₹100.4 Cr (up 55.8% YoY). Total assets are valued at ₹180.95 Cr (up 46.2% YoY).

The company has about 47 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: Trident Lifeline. As per MCA filings, the company has open charges of ₹142.39 Cr and satisfied charges of ₹1.58 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending. The company has 19 deals on record (13 secondary share transfers, 4 funding rounds, 1 rights issue), with disclosed funding of ₹6.79 Cr; the latest was in October 2022. The company has 13 MSME Form 1 returns on record between 2019 and 2023, listing 435 overdue payments to 43 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tridentlifeline.com.

Company details

CIN L51909GJ2014PLC078227
Registration Number 078227
Incorporation Date 09 January 2014
ROC Ahmedabad
Listing Status Listed - Listed on BSE (543616)
Company Status Active
Compliance Status Active Compliant

CIN history

Trident Lifeline has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L51909GJ2014PLC078227, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L51909GJ2014PLC078227Current
U51909GJ2014PTC078227Previous
U51909GJ2014PLC078227Previous

Contact details

Trident Lifeline Limited's registered office is in Surat, Gujarat. Its website is tridentlifeline.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    2nd Floor Shop – 2004 North Extension Falsawadi Begumpura Nodh – 4/1650 Sahara Darwaja, Surat, Gujarat, India – 395003
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Trident Lifeline Limited, buy the company report.

Comprehensive company report
Trident Lifeline Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Trident Lifeline operates one associated brand: Trident Lifeline. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturer of liquid orals, topical preparations, capsule, and other drugstridentlifeline.com

Business activity

The main business activity of Trident Lifeline is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Trident Lifeline Limited, buy the company report.

Financials of Trident Lifeline Limited

FY 2025-26 filings available

Trident Lifeline Limited reported revenue of ₹129.02 Cr (up 48.4% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹129 Cr
+48.4% YoY
EBITDA
₹28.11 Cr
+87.4% YoY
Profit After Tax
₹19.03 Cr
+62.2% YoY
Net Worth
₹100 Cr
+55.8% YoY
Total Assets
₹181 Cr
+46.2% YoY
Total Debt
₹72.99 Cr
+35.1% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Income statement
Revenue12986.9644.6331.6921.77
Revenue growth+48.4%+94.9%+40.8%+45.6%-
EBITDA28.1115.008.236.262.71
EBITDA margin+21.8%+17.3%+18.4%+19.8%+12.5%
Profit before tax27.1913.608.696.582.98
Net profit19.0311.736.336.023.94
Net profit margin+14.8%+13.5%+14.2%+19.0%+18.1%
EPS (₹)16.3210.225.525.234.93
Balance sheet
Total assets18112472.4354.877.30
Net worth10064.4652.9045.644.78
Total debt72.9954.0318.417.692.46
Cash & bank4.222.466.6513.780.16
Net working capital84.5658.5837.3241.514.13
Cash flow
Cash from operations4.69(3.98)2.23(19.00)(0.21)
Cash from investing(36.61)(13.71)(20.36)(9.69)(0.45)
Cash from financing33.6813.5011.0142.280.80
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue47.0833.7249.9525.7131.3423.6134.0111.83
Revenue growth (YoY)+50.2%+42.8%+46.9%+117.3%+102.9%+79.5%--
Other income0.970.571.624.631.671.351.870.56
EBITDA11.328.5210.985.096.865.178.534.08
EBITDA margin+24.0%+25.3%+22.0%+19.8%+21.9%+21.9%+25.1%+34.5%
Depreciation1.561.621.232.460.911.462.740.61
Interest1.930.860.771.240.991.131.550.55
Profit before tax8.806.6110.606.026.633.936.113.48
Tax2.211.543.821.371.541.15(0.02)0.92
Net profit6.595.076.784.655.092.786.132.56
EPS (₹)5.694.275.763.724.272.666.152.42
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue10267.8044.6531.6921.779.624.93
Revenue growth+50.3%+51.9%+40.9%+45.6%+126.3%+95.1%-
EBITDA24.3317.668.876.262.711.26(0.28)
EBITDA margin+23.9%+26.1%+19.9%+19.8%+12.5%+13.1%-5.7%
Profit before tax24.9817.899.796.572.980.87(1.09)
Net profit18.0913.047.036.013.940.65(0.82)
Net profit margin+17.8%+19.2%+15.7%+19.0%+18.1%+6.8%-16.6%
EPS (₹)15.5011.356.135.234.931.26(2.57)
Balance sheet
Total assets12480.6958.9449.087.304.113.52
Net worth99.0965.7352.6845.634.78(0.47)(3.00)
Total debt24.6014.896.203.382.464.536.46
Cash & bank4.072.116.0113.770.130.090.12
Net working capital75.5452.4938.6940.444.110.40(0.05)
Cash flow
Cash from operations7.931.970.90(16.60)(0.19)1.48(0.59)
Cash from investing(20.07)(7.88)(11.01)(5.56)(0.50)(0.56)(0.08)
Cash from financing14.102.012.3535.800.80(0.96)0.76
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue32.7326.8431.9723.6746.2618.8220.8516.51
Revenue growth (YoY)-29.3%+42.6%+53.3%+43.4%+195.4%+27.7%--
Other income0.930.531.640.891.640.541.610.54
Total expenses22.9819.6225.2317.3934.9513.8915.2712.37
EBITDA9.757.226.746.2811.314.935.584.14
EBITDA margin+29.8%+26.9%+21.1%+26.5%+24.4%+26.2%+26.8%+25.1%
Depreciation0.570.700.040.711.110.510.710.38
Interest1.320.490.380.540.740.330.460.35
Profit before tax8.796.567.965.9211.104.636.023.95
Tax2.211.542.291.912.691.151.660.92

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 21 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue47.0833.7249.9525.7131.3423.6134.0111.83
Revenue growth (YoY)+50.2%+42.8%+46.9%+117.3%+102.9%+79.5%--
Other income0.970.571.624.631.671.351.870.56
EBITDA11.328.5210.985.096.865.178.534.08
EBITDA margin+24.0%+25.3%+22.0%+19.8%+21.9%+21.9%+25.1%+34.5%
Depreciation1.561.621.232.460.911.462.740.61
Interest1.930.860.771.240.991.131.550.55
Profit before tax8.806.6110.606.026.633.936.113.48
Tax2.211.543.821.371.541.15(0.02)0.92
Net profit6.595.076.784.655.092.786.132.56
EPS (₹)5.694.275.763.724.272.666.152.42
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Revenue12986.9644.6331.6921.77
Revenue growth+48.4%+94.9%+40.8%+45.6%-
Other income9.278.232.081.160.60
Total expenses10171.9636.4025.4319.06
Employee cost0.0010.892.291.391.10
EBITDA28.1115.008.236.262.71
EBITDA margin+21.8%+17.3%+18.4%+19.8%+12.5%
Depreciation6.075.490.970.360.20
Interest4.124.140.650.480.13
Profit before tax27.1913.608.696.582.98
Tax7.883.122.750.56(0.96)
Net profit19.0311.736.336.023.94
Net profit margin+14.8%+13.5%+14.2%+19.0%+18.1%
EPS (₹)16.3210.225.525.234.93
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Equity & liabilities
Share capital11.9311.5011.5011.508.00
Reserves & surplus84.7452.9640.4134.14(3.22)
Shareholders' funds (net worth)10064.4652.9045.644.78
Minority interest7.495.191.051.470.00
Secured loans56.6541.1514.426.200.60
Unsecured loans16.3412.883.991.491.86
Total debt72.9954.0318.417.692.46
Total liabilities18112472.4354.877.30
Assets
Gross block78.3057.4023.034.332.23
Net block60.7043.8720.893.161.43
Capital work in progress17.541.604.034.830.00
Investments8.2710.723.773.340.00
Inventories36.4428.2412.587.173.71
Sundry debtors73.6527.6813.4412.094.97
Cash & bank balances4.222.466.6513.780.16
Loans & advances25.1831.9919.2916.171.83
Total current assets13990.3751.9649.2110.67
Total current liabilities54.9331.7914.647.706.54
Net working capital84.5658.5837.3241.514.13
Total assets18112472.4354.877.30
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Opening cash2.466.6513.780.180.01
Net cash from operating activities4.69(3.98)2.23(19.00)(0.21)
Net cash from investing activities(36.61)(13.71)(20.36)(9.69)(0.45)
Net cash from financing activities33.6813.5011.0142.280.80
Net change in cash1.76(4.19)(7.13)13.600.14
Closing cash4.222.466.6513.780.16
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Growth
Sales growth+48.4%+94.9%+40.8%+45.6%-
EBITDA growth+87.4%+82.3%+31.5%+131.0%-
PBT growth+100.1%+56.5%+32.1%+120.8%+9997.0%
Net income growth+62.2%+85.3%+5.2%+52.8%-
Revenue CAGR (3Y)+59.7%+58.7%---
EBITDA CAGR (3Y)+65.1%+76.9%---
Profitability & leverage
Net income margin+15.0%+12.1%+13.3%+19.0%+18.1%
Return on capital employed+22.3%+18.7%+15.0%+22.1%+29.7%
Return on net worth+23.4%+17.9%+12.1%+22.4%+49.4%
Debt / equity0.770.620.260.200.51
Long-term debt / equity0.430.380.170.100.30
Interest cover24.0943.538.958.145.18
Efficiency & per share
Fixed asset turnover1.902.163.269.669.76
Inventory turnover3.994.264.525.835.87
Debtors turnover2.554.233.503.724.38
EPS (₹)15.9610.225.525.234.93
Dividend per share (₹)0.000.000.000.000.00
Book value per share (₹)81.0256.0545.1439.695.97
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue32.7326.8431.9723.6746.2618.8220.8516.51
Revenue growth (YoY)-29.3%+42.6%+53.3%+43.4%+195.4%+27.7%--
Other income0.930.531.640.891.640.541.610.54
Total expenses22.9819.6225.2317.3934.9513.8915.2712.37
EBITDA9.757.226.746.2811.314.935.584.14
EBITDA margin+29.8%+26.9%+21.1%+26.5%+24.4%+26.2%+26.8%+25.1%
Depreciation0.570.700.040.711.110.510.710.38
Interest1.320.490.380.540.740.330.460.35
Profit before tax8.796.567.965.9211.104.636.023.95
Tax2.211.542.291.912.691.151.660.92
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue10267.8044.6531.6921.779.624.93
Revenue growth+50.3%+51.9%+40.9%+45.6%+126.3%+95.1%-
Other income4.173.142.201.150.600.160.07
Total expenses77.5750.1435.7825.4319.068.365.21
Employee cost0.002.511.551.391.100.700.71
EBITDA24.3317.668.876.262.711.26(0.28)
EBITDA margin+23.9%+26.1%+19.9%+19.8%+12.5%+13.1%-5.7%
Depreciation1.861.530.770.360.200.140.12
Interest1.661.380.510.480.130.410.76
Profit before tax24.9817.899.796.572.980.87(1.09)
Tax6.894.852.750.56(0.96)0.22(0.28)
Net profit18.0913.047.036.013.940.65(0.82)
Net profit margin+17.8%+19.2%+15.7%+19.0%+18.1%+6.8%-16.6%
EPS (₹)15.5011.356.135.234.931.26(2.57)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital11.9311.5011.5011.508.005.003.10
Reserves & surplus83.4354.2341.1834.13(3.22)(5.47)(6.10)
Shareholders' funds (net worth)99.0965.7352.6845.634.78(0.47)(3.00)
Secured loans21.2013.026.202.730.600.000.00
Unsecured loans3.401.870.000.651.864.536.46
Total debt24.6014.896.203.382.464.536.46
Total liabilities12480.6958.9449.087.304.113.52
Assets
Gross block33.9118.269.554.272.231.771.22
Net block28.5914.807.623.111.431.180.77
Capital work in progress0.000.544.030.230.000.000.00
Investments19.7412.494.404.040.050.000.00
Inventories23.2216.5711.067.173.715.270.94
Sundry debtors49.3420.4013.7612.154.970.641.31
Cash & bank balances4.072.116.0113.770.130.090.12
Loans & advances33.4130.0522.1514.771.831.740.45
Total current assets11069.1352.9847.8610.647.742.82
Total current liabilities34.5016.6414.297.426.537.342.87
Net working capital75.5452.4938.6940.444.110.40(0.05)
Total assets12480.6958.9449.087.304.113.52
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash2.116.0113.770.130.010.120.04
Net cash from operating activities7.931.970.90(16.60)(0.19)1.48(0.59)
Net cash from investing activities(20.07)(7.88)(11.01)(5.56)(0.50)(0.56)(0.08)
Net cash from financing activities14.102.012.3535.800.80(0.96)0.76
Net change in cash1.96(3.90)(7.76)13.640.11(0.03)0.08
Closing cash4.072.116.0113.770.130.090.12
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+50.3%+51.9%+40.9%+45.6%+126.3%+95.1%-
EBITDA growth+37.8%+99.1%+41.7%+131.0%+115.1%+550.0%-
PBT growth+39.6%+82.7%+49.0%+120.5%+242.5%+9998.0%+9997.0%
Net income growth+38.7%+85.5%+17.0%+52.5%+506.2%+179.3%-
Revenue CAGR (3Y)+47.6%+46.0%+66.8%+85.9%---
EBITDA CAGR (3Y)+57.3%+86.8%+91.7%----
Profitability & leverage
Net income margin+17.8%+19.2%+15.8%+19.0%+18.1%+6.8%-16.4%
Return on capital employed+26.1%+27.6%+19.1%+23.7%+31.0%+19.2%0.0%
Return on net worth+22.0%+22.0%+14.3%+22.4%+60.8%+63.0%0.0%
Debt / equity0.240.180.100.121.620.000.00
Long-term debt / equity0.080.080.040.041.360.000.00
Interest cover7.478.566.308.145.1836.61-190.00
Efficiency & per share
Fixed asset turnover3.914.886.469.7510.896.434.04
Inventory turnover5.124.914.905.834.853.105.24
Debtors turnover2.923.973.453.707.769.873.76
EPS (₹)15.1611.356.135.234.931.26(2.57)
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)79.9157.1645.8139.685.97(0.94)(9.69)

To see the full year-wise statements and ratios of Trident Lifeline Limited, buy the company report.

Board of directors of Trident Lifeline Limited

Trident Lifeline has 8 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Hardik Jigishkumar DesaiDirector27 Jun 20224 Years 4 MonthsCurrent
Shravan H PatelManaging Director04 Jul 20224 Years 4 MonthsCurrent
Ashish Anandsingh BafnaDirector01 Sep 20251 Years 2 MonthsCurrent
Rupaben Chetan JariwalaWhole-Time Director16 May 20242 Years 6 MonthsCurrent
Falguni Bhavesh JariwalaDirector27 Apr 20242 Years 6 MonthsCurrent
Mishal Shailesh PatelDirector22 Jul 20233 Years 4 MonthsCurrent
Showing 6 of 8 current directors. View all directors

Auditor

Trident Lifeline Limited is audited by A Bafna & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
A Bafna & AssociatesFY 2023121901W

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 62.60%, foreign institutional investors hold 5.20%, domestic institutional investors hold 0.30% and retail and other public shareholders hold 31.90%.

Promoters: 62.60%DII (Domestic Institutional): 0.30%FII (Foreign Institutional): 5.20%Retail & Others: 31.90%
Sep 2026
QUARTER
62.60% Promoters
0.30% DII (Domestic Institutional)
5.20% FII (Foreign Institutional)
31.90% Retail & Others
Promoter holding - history
Now 62.60% · Sep 2026High 64.10% · Mar 2026Low 62.60% · Sep 2026
61%62.3%63.5%64.8%66%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 63.10%Mar 2026: 64.10%Jun 2026: 62.80%Sep 2026: 62.60%64.10%62.60%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters62.60%62.80%64.10%63.10%
Public37.40%37.20%35.90%36.90%

Charges & borrowings

Open charges
₹142.39 Cr
Satisfied charges
₹1.58 Cr
Breakdown by lending institutions
Axis Bank Limited₹63.18 Cr
Yes Bank Limited₹46.03 Cr
Others₹30.40 Cr
Sidbi₹2.78 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Aug 2026101389751Axis Bank Limited₹2.29 CrOpen
14 Jul 2026101389789Axis Bank Limited₹2.29 CrOpen
25 Jun 2026101323896Others₹15 CrOpen
12 Jun 2026101323897Others₹15 CrOpen
03 Nov 2025101182491Others₹39.98 LakhOpen

To see the full charge records of Trident Lifeline Limited, buy the company report.

Total charge records: 19 View all charges

Deals & funding

Trident Lifeline Limited has 19 deals on record (13 secondary share transfers, 4 funding rounds, 1 rights issue), with disclosed funding of ₹6.79 Cr; the latest was in October 2022.

Total deals
19
Secondary share transfers
13
Funding rounds
4
Rights issue
1
IPO
1
Disclosed funding
₹6.79 Cr

Deals on record (5 of 19)

WhenDealAmountParties
Oct 2022IPO₹35.34 CrInvestors: IPO - Trident Lifeline Limited, NAV Capital VCC- NAV Capital Emerging Star Fund, Bijal Mukesh Shah Huf, an individual
Dec 2016Secondary share transferUndisclosedBuyer: an individual
Seller: Trident Texofab Limited
Dec 2016Rights issue₹1.2 CrInvestors: Trident Texofab Limited , 3 individuals
Mar 2016Secondary share transferUndisclosedBuyer: 4 individuals
Seller: Trident Texofab Limited , 2 individuals
Mar 2014Secondary share transferUndisclosedBuyer: Trident Texofab Limited
Seller: an individual

To see the full deal history of Trident Lifeline Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Trident Lifeline Limited has 13 MSME Form 1 returns on record between 2019 and 2023, listing 435 overdue payments to 43 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 43)

SupplierAmount dueDue sinceReported on
an individual supplier
an individual supplier
an individual supplier
Shreeji Sharan Pharmapack LLP
an individual supplier

To see the full MSME payment records of Trident Lifeline Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Trident Lifeline has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
TNS Pharma Private LimitedU24290GJ2021PTC128263

To see the full group structure of Trident Lifeline Limited, buy the company report.

Employees & EPFO

Trident Lifeline Limited has a workforce of 47 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
47
Active EPFO establishments
1
Employee growth
-7.8%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2747
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18

To see the full employee and EPFO history of Trident Lifeline Limited, buy the company report.

GST

Trident Lifeline has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAECT8906D1ZGGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Trident Lifeline Limited, buy the company report.

Recent activity

Trident Lifeline Limited has 17 board changes on record since 2020: 12 appointments and 5 cessations. The latest: Sachin Bhandari was appointed as Director on 13 Jun 2026.

Charges
A charge with Yes Bank Limited of Rs. 10.00 Cr registered on 27 Apr 2025 with Charge ID 101098176 was modified on 14 Aug 2026.
Charges
A charge with Axis Bank Limited amounted to Rs. 2.29 Cr with Charge ID 101389751 was registered on 04 Aug 2026.
Charges
A charge with Axis Bank Limited amounted to Rs. 2.29 Cr with Charge ID 101389789 was registered on 14 Jul 2026.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101323896 was registered on 25 Jun 2026.
Appointed
Sachin Bhandari was appointed as Director.
Appointed
Smita Kiran Davda was appointed as Director.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101323897 was registered on 12 Jun 2026.
Filing
Trident Lifeline Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ahmedabad.
Ceased
Maniya Hardik Desai ceased to be Director.
Charges
A charge with Others amounted to Rs. 0.40 Cr with Charge ID 101182491 was registered on 03 Nov 2025.
AGM
Trident Lifeline Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Appointed
Ashish Anandsingh Bafna was appointed as Director.

36 earlier events are in the company report.

Frequently asked questions

Trident Lifeline is an active public limited company based in Surat, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 January 2014 (12+ years old) and is registered under CIN L51909GJ2014PLC078227. Listed on BSE: 543616.

Trident Lifeline reported revenue of ₹129.02 Cr for FY 2025-26 (up 48.4% YoY) based on consolidated financials.

Trident Lifeline has 8 current directors:

The latest financial statements of Trident Lifeline on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Trident Lifeline is 24AAECT8906D1ZG, registered in Gujarat.

The CIN (Corporate Identification Number) of Trident Lifeline is L51909GJ2014PLC078227. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Trident Lifeline is a listed company as per MCA records. Its shares are listed on BSE (code: 543616).

Trident Lifeline has 2 court cases on record: 2 filed by the company. 1 is pending. Most are in the high courts.

Trident Lifeline was incorporated on 09 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Trident Lifeline has 19 deals on record (13 secondary share transfers, 4 funding rounds, 1 rights issue), with disclosed funding of ₹6.79 Cr; the latest was in October 2022.

Sachin Bhandari was appointed as Director on 13 Jun 2026. Smita Kiran Davda was appointed as Director on 13 Jun 2026. Maniya Hardik Desai ceased to be Director on 22 Nov 2025. Trident Lifeline has 17 board changes on record in total.